Related Experiment Videos
Alemtuzumab: a new option for refractory chronic lymphocytic leukemia?
1Gynecologic Oncology Pharmacology Research, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Cancer Practice
|March 7, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Free radical generation in hydroperoxide-treated erythrocytes monitored continuously by luminol-amplified chemiluminescence.
Biochemistry international·1992
Role of guinea pig and rabbit hepatic aldehyde oxidase in oxidative in vitro metabolism of cinchona antimalarials.
Drug metabolism and disposition: the biological fate of chemicals·1992
Comparison of intravenous contrast agents for CT studies in children.
Acta radiologica (Stockholm, Sweden : 1987)·1992
kappa-Opioid inhibition of [3H]dopamine release from rat ventral mesencephalic dissociated cell cultures.
Molecular pharmacology·1992
Prodromal symptoms in manic depressive psychosis.
Social psychiatry and psychiatric epidemiology·1992
Saphenous vein graft pseudoaneurysm formation after postoperative mediastinitis.
The Annals of thoracic surgery·1992
Bladder cancer: epidemiology, diagnosis, and management.
Cancer practice·2002
Patient and caregiver interest in internet-based cancer services.
Cancer practice·2002
Tapestry: a retreat program of support for persons living with cancer.
Cancer practice·2002
Viatical settlements: effects on terminally ill patients.
Cancer practice·2002
Adherence to moderate-intensity exercise during breast cancer therapy.
Cancer practice·2002
Survivorship resources for post-treatment cancer survivors.
Cancer practice·2002
Serological correlates of disseminated Borrelia burgdorferi infection in mouse models of tick challenge.
Microbiology spectrum·2026
IgG4-related disease - treatment with anti-CD20, anti-CD19 antibodies, and other new drugs.
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
[Advances in mechanical signal-regulated tumor immunity and its therapeutic development].
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences·2026
Cytokine-independent activation of STAT5 promotes the persistence and function of CD4+ regulatory T cells.
Molecular therapy. Advances·2026
CAR design equips diverse immune cells with unique antigen-specific activation identities.
Molecular therapy. Oncology·2026